Literature DB >> 21692412

Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma.

L Slovacek1, P Priester, J Petera, I Slanska, J Kopecky.   

Abstract

The authors report on a case of tamoxifen/norfloxacin interaction leading to QT interval prolongation in an 83-year-old female patient with extracranial meningioma treated with radiation and hormonal therapy (with Tamoxifen). This case report highlights the potential risk of tamoxifen causing depression of electrical impulse in sinoatrial node, leading to symptomatic sinus bradycardia with prolonged QT interval. At the same time it indicates the need to be on the look out for drug interactions (in our case between tamoxifen and norfloxacin), as well as to be aware of other drugs possibly inducing QT interval prolongation (Fig. 2, Ref. 7).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692412

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  2 in total

1.  Induced Trf2 deletion leads to aging vascular phenotype in mice associated with arterial telomere uncapping, senescence signaling, and oxidative stress.

Authors:  R Garrett Morgan; Ashley E Walker; Daniel W Trott; Daniel R Machin; Grant D Henson; Kelly D Reihl; Richard M Cawthon; Eros L Denchi; Yu Liu; Samuel I Bloom; Tam T Phuong; Russell S Richardson; Lisa A Lesniewski; Anthony J Donato
Journal:  J Mol Cell Cardiol       Date:  2018-11-29       Impact factor: 5.000

2.  Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People.

Authors:  C Franchi; I Ardoino; R Rossio; A Nobili; E M Biganzoli; A Marengoni; M Marcucci; L Pasina; M Tettamanti; S Corrao; P M Mannucci
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.